Related Experiment Videos
Isobutyl cyanoacrylate nanoparticles as a solid phase for an efficient immunoradiometric assay
Biomaterials
|May 1, 1986
Summary
Monoclonal antibodies and serum proteins bind effectively to cyanoacrylic nanoparticles, maintaining immunoreactivity. This enables a new assay for detecting low levels of alpha-fetoprotein.
Area of Science:
- Biomaterials Science
- Immunotechnology
- Nanotechnology
Background:
- Development of nanoparticle-based assays requires understanding protein interactions.
- Cyanoacrylic nanoparticles offer potential for bioconjugation.
Purpose of the Study:
- To investigate the binding characteristics of monoclonal antibodies and serum proteins to cyanoacrylic nanoparticles.
- To evaluate the stability and immunoreactivity of antibody-coated nanoparticles.
- To develop a novel assay for alpha-fetoprotein (AFP) detection.
Main Methods:
- Coating of cyanoacrylic nanoparticles with monoclonal antibodies and serum proteins.
- Characterization of adsorption kinetics and binding capacity.
- Assessment of linkage stability and retained immunoreactivity.
- Development and validation of a competitive immunoradiometric assay.
Main Results:
- High binding capacity and rapid adsorption kinetics observed for proteins and antibodies.
- Stable linkage formed between nanoparticles and biomolecules.
- Immunoreactivity of antibodies was preserved after nanoparticle conjugation.
- The developed assay detected alpha-fetoprotein down to 0.1 ng per assay.
Conclusions:
- Cyanoacrylic nanoparticles are suitable for antibody and protein immobilization.
- Nanoparticle-based assays can maintain biological activity.
- A sensitive immunoradiometric assay for AFP has been developed using these nanoparticles.